Small-hairpin (sh) RNA targeting B7-H3 in combination with the Ara-c drug was found to upregulate antineoplastic activity and cause 80% tumor reduction in histiocytic lymphoma compared to 40% with Ara-c alone [129]. The gene discussed is CD276; the disease is neoplasm.